Stocks ACDC Financial statements
Financial statementsProFrac Holding Corp. financial statements
Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data ProFrac Holding Corp. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2020 | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Revenue | 548 | 768 | 2,426 | 2,630 | 2,191 | 1,942 |
| Cost of revenue | 548 | 768 | 2,426 | 1,740 | 1,495 | 1,455 |
| Gross profit | 0 | 0 | 0 | 890 | 696 | 487 |
| Selling, general and administrative | 48.2 | 64.2 | 225 | 234 | 205 | 191 |
| Operating income | -95 | -18 | 412 | 167 | -60.4 | -226 |
| Interest expense | 23.3 | 25.8 | 59.5 | 155 | 157 | 139 |
| Other non-operating income | 0.3 | 0.6 | 16.5 | -36.2 | 3 | -3.8 |
| Pre-tax income | -118 | -43.7 | 352 | -58 | -215 | -368 |
| Income tax | 0.5 | -0.2 | 9.1 | 1.2 | -7 | -12.9 |
| Net income | -119 | -42.4 | 91.5 | -97.7 | -215 | -369 |
| EBITDA | 55.7 | 123 | 680 | 605 | 382 | 191 |
| EPS, basic | 2.06 | -0.82 | -1.38 | -2.22 | ||
| EPS, diluted | 2.06 | -0.82 | -1.38 | -2.22 | ||
| Shares, basic (weighted) | 44.3 | 131 | 160 | 168 | ||
| Shares, diluted (weighted) | 44.5 | 131 | 160 | 168 |
Balance sheet
| FY2020 | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Cash and equivalents | 3 | 5.4 | 35.1 | 25.3 | 14.8 | 22.9 |
| Receivables | 162 | 536 | 346 | 313 | 267 | |
| Inventory | 74 | 250 | 237 | 201 | 151 | |
| Other current assets | 6.2 | 43.2 | 23.3 | 29.4 | 22.6 | |
| Total current assets | 252 | 3 | 638 | 574 | 484 | |
| Property, plant and equipment | 364 | 1,396 | 1,779 | 1,761 | 1,464 | |
| Lease right-of-use assets | 113 | 87.2 | 159 | 154 | ||
| Goodwill | 241 | 326 | 302 | 290 | ||
| Intangible assets | 27.8 | 203 | 174 | 149 | 112 | |
| Long-term investments | 4.2 | 58.6 | 28.9 | 7.5 | ||
| Other non-current assets | 17.2 | 56.3 | 37.8 | 43.3 | 40 | |
| Total assets | 665 | 1,282 | 3,071 | 2,988 | 2,573 | |
| Accounts payable | 137 | 339 | 319 | 324 | 257 | |
| Accrued liabilities | 22.5 | 104 | 65.6 | 67.2 | 74 | |
| Deferred revenue | 23.1 | 7.3 | 7.4 | 0.8 | ||
| Short-term debt | 31.8 | 128 | 126 | 160 | 145 | |
| Total current liabilities | 247 | 3.4 | 649 | 660 | 597 | |
| Long-term debt | 270 | 798 | 942 | 944 | 876 | |
| Lease liabilities | 81 | 67.8 | 137 | 116 | ||
| Other non-current liabilities | 20.2 | 15.2 | 9.2 | 10.1 | ||
| Total liabilities | 517 | 3.4 | 1,742 | 1,849 | 1,692 | |
| Total debt | 235 | 735 | 924 | 936 | 833 | |
| Paid-in capital | 1,225 | 1,241 | 1,326 | |||
| Retained earnings | -1,186 | -16 | -236 | -610 | ||
| Shareholders' equity | 147 | -1,184 | 1,211 | 1,007 | 718 | |
| Minority interests | 1 | 72.2 | 58.7 | 69.2 | 94.4 | |
| Total equity | 148 | -1,112 | 1,270 | 1,076 | 812 | |
| Total liabilities and equity | 665 | 1,282 | 3,071 | 2,988 | 2,573 |
Cash flow statement
| FY2020 | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Net income | -119 | -42.4 | 343 | -59.2 | -208 | -356 |
| Depreciation and amortization | 151 | 141 | 267 | 438 | 442 | 416 |
| Stock-based compensation | 67.4 | 29.8 | 7.3 | 9.3 | ||
| Deferred income tax | 3.7 | 0.1 | -10.7 | -14.1 | ||
| Change in receivables | 12.4 | -89.6 | -203 | 205 | 55.5 | 26.9 |
| Change in inventory | -3.5 | -16.1 | -105 | 19.1 | 64.7 | 38.8 |
| Change in payables | -5.1 | 31.6 | 42.9 | -68.2 | -7.6 | -22.4 |
| Cash from operations | 45.1 | 43.9 | 415 | 554 | 367 | 190 |
| Capital expenditures | -48 | -87.4 | -356 | -267 | -255 | -170 |
| Acquisitions | -1.3 | -4.3 | -641 | -455 | -194 | |
| Cash from investing | -44.6 | -78.4 | -1,029 | -716 | -372 | -164 |
| Debt issued | 86.4 | 160 | 819 | 1,220 | 137 | 119 |
| Debt repaid | -80.1 | -147 | -532 | -947 | -157 | -136 |
| Stock issued | 329 | 0 | 83 | |||
| Cash from financing | -15.3 | 36.9 | 646 | 150 | -5.5 | -17.7 |
| Net change in cash | -14.8 | 2.4 | 32.5 | -12.6 | -10.5 | 8.1 |
| Free cash flow | -2.9 | -43.5 | 59 | 287 | 112 | 19.6 |
| Interest paid | 21 | 23.5 | 35 | 139 | 138 | 126 |
| Income taxes paid | 0.4 | -0.2 | 4.8 | 0.3 | 3 | 2.1 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 21.5% | Gross profit / revenue. |
| Operating margin | -15.0% | Operating income / revenue. |
| EBITDA margin | 7.4% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | -22.4% | Pre-tax income / revenue. |
| Net margin | -22.8% | Net income / revenue. |
| FCF margin | -3.4% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 4.8% | Cash from operations / revenue. |
| Return on equity (ROE) | -75.0% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | -16.2% | Net income / average total assets. |
| Return on invested capital (ROIC) | -15.1% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| SG&A / revenue | 9.7% | Selling, general and administrative expense / revenue. |
| Stock-based pay / revenue | 0.6% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 8.2% | Capital expenditures / revenue. |
| D&A / revenue | 22.4% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | -11.4% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | -7.1% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 28.8% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | -30.0% | Gross profit vs the same period a year earlier. Only from a positive base. |
| EBITDA growth, 1y | -50.1% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | -34.6% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA CAGR, 5y | 27.9% | Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | -48.4% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | -23.0% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | 33.3% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | -82.5% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | -30.7% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value growth, 1y | -28.7% | Book value vs the same period a year earlier. Only from a positive base. |
| Total assets growth, 1y | -13.9% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 26.1% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Share count change, 1y | 5.3% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 55.8% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 0.84x | Current assets / current liabilities. |
| Quick ratio | 0.52x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.03x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 1.62x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 35.0% | Total debt / total assets. |
| Liabilities / assets | 71.4% | Total liabilities / total assets. |
| Net debt | $858.9M | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Net debt / EBITDA | 6.53x | Net debt / EBITDA (twelve months), when EBITDA is positive. |
| Interest coverage | -2.00x | Operating income / interest expense. |
| Working capital | -$105.0M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 15.3% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $158.5M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.71x | Revenue / average total assets. |
| Fixed asset turnover | 1.32x | Revenue / average property, plant and equipment. |
| Inventory turnover | 8.03x | Cost of revenue / average inventory. |
| Days inventory | 45 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 5.35x | Revenue / average receivables. |
| Days sales outstanding | 68 days | 365 x average receivables / revenue. |
| Days payables | 84 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | 29 days | Days inventory + days sales outstanding - days payables. |
| Capex / operating cash flow | 170.3% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | -$2.23 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $9.82 | Revenue / diluted weighted shares. |
| FCF per share | -$0.33 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $0.47 | Cash from operations / diluted weighted shares. |
| Book value per share | $2.98 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $0.87 | Tangible book value / shares outstanding. |
| Cash per share | $0.10 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $838.7M | Share price x shares outstanding. |
| Enterprise value | $1.70B | Market cap + total debt - cash - short-term investments. |
| P/S | 0.47x | Market cap / revenue. |
| P/B | 1.55x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 5.29x | Market cap / tangible book value, when positive. |
| P/OCF | 9.72x | Market cap / cash from operations, when positive. |
| EV/Sales | 0.95x | Enterprise value / revenue. |
| EV/EBITDA | 12.9x | Enterprise value / EBITDA, when both are positive. |
| FCF yield | -7.2% | Free cash flow / market cap. |
| Earnings yield | -48.5% | Net income / market cap (the inverse of P/E). |
What was ProFrac Holding Corp.'s revenue in fiscal 2025?
ProFrac Holding Corp. reported revenue of $1.94B for fiscal 2025, 11.4% lower than the year before.
Was ProFrac Holding Corp. profitable in fiscal 2025?
No. It reported a net loss of $369.0M.
How much free cash flow did ProFrac Holding Corp. generate in fiscal 2025?
Cash from operations of $189.5M minus capital expenditures of $169.9M left free cash flow of $19.6M.